| Literature DB >> 35795304 |
Saeed M Omar1, Osama S Osman1, Gasim I Gasim2, Ishag Adam3.
Abstract
Purpose: Sub-Saharan Africa suffers from a dual impact of communicable (CDs) and non-communicable diseases (NCDs). There is scarce data on causes, trends of admission, and deaths among patients in Sudan. We aimed to determine the causes, trends of admission, and mortality among adult patients admitted to Gadarif Hospital in Eastern Sudan. Patients andEntities:
Keywords: Sudan; cardiovascular diseases; communicable diseases; mortality
Year: 2022 PMID: 35795304 PMCID: PMC9252602 DOI: 10.2147/IJGM.S367513
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
In Patient Characteristics of the Adult in-Patients (Number=7230) at Gadarif Hospital During 2017–2020 in Eastern Sudan
| Characteristic | Overall (n=7230,100%) | 2017 (n=2104, 29.1%) | 2018 (n=1999, 27.6%) | 2019 (n=1666, 23.0%) | 2020 (n=1461, 20.2%) | P value | |
|---|---|---|---|---|---|---|---|
| Age, years | 47.0 (35.0) | 48.5 (35.0) | 48.0 (35.0) | 45.0 (36.0) | 47 (35.5) | <0.001 | |
| Sex | Male | 5009 (69.3) | 1388 (66.0) | 1366 (68.3) | 1187 (71.2) | 1068 (73.1) | <0.001 |
| Female | 2221 (34.7) | 716 (34.0) | 633 (31.7) | 479 (28.2) | 393 (26.9) | ||
| Type of the diseases | Communicable | 3167 (43.8) | 934 (44.4) | 840 (42.0) | 740 (44.4) | 653 (44.7) | 0.308 |
| Non-communicable | 4063 (56.2) | 1170 (55.6) | 1159 (58.0) | 926 (55.6) | 808 (55.3) | ||
| Death | No | 6556 (90.7) | 1905 (90.5) | 1812 (90.6) | 1511 (90.7) | 1328 (90.9) | 0.994 |
| Yes | 674 (9.3) | 199 (9.5) | 187 (9.4) | 155 (9.3) | 133(9.1) | ||
Frequency (Proportions) of the Pattern of Admission of the Communicable and Non-Communicable Disease During 2017–2020 in Gadarif Hospital in Eastern Sudan
| Disease | Total (n=7230) | 2017 (n=2104) | 2018 (n=1999) | 2019 (n=1666) | 2020 (n=1461) | P |
|---|---|---|---|---|---|---|
| Visceral leishmaniasis | 867 (12.0) | 246 (11.7) | 213 (10.7) | 196 (11.8) | 212 (14.5) | 0.006 |
| Sepsis | 511 (7.1) | 142 (6.7) | 125 (6.3) | 130 (7.8) | 114 (7.8) | 0.178 |
| Severe malaria | 488 (6.7) | 124 (5.9) | 116 (5.8) | 151 (9.1) | 97 (6.6) | < 0.001 |
| Gastroenteritis | 436 (6.0) | 147 (7.0) | 120 (6.0) | 98 (5.9) | 71 (4.9) | 0.072 |
| Tuberculosis | 416 (5.8) | 126 (6.0) | 119 (6.0) | 78 (4.7) | 93 (6.4) | 0.179 |
| Severe pneumonia | 321 (4.4) | 108 (5.1) | 91 (4.6) | 70 (4.2) | 52 (3.6) | 0.149 |
| Viral hepatitis | 166 (2.3) | 42 (2.0) | 54 (2.7) | 34 (2.0) | 36 (2.5) | 0.396 |
| Urinary tract infection | 147 (2.0) | 53 (2.5) | 40 (2.0) | 30 (1.8) | 24 (1.6) | 0.254 |
| HIV | 111(1.5) | 28 (1.3) | 31 (1.6) | 29 (1.7) | 23 (1.6) | 0.786 |
| Enteric fever | 16 (0.2) | 3(0.3) | 6 (0.3) | 5 (0.3) | 2 (0.1) | 0.553 |
| Others /combined | 147 (2.0) | 53 (2.5) | 40 (2.0) | 30 (1.8) | 24 (1.6) | 0.254 |
| Cardiovascular diseases | 1331 (18.4) | 426 (20.2) | 388 (19.4) | 272 (16.3) | 245 (16.8) | 0.004 |
| Snake bite | 932 (12.9) | 230 (10.9) | 176 (8.8) | 242 (14.5) | 187 (12.8) | 0.007 |
| Renal diseases | 683 (9.4) | 185 (8.8) | 119 (6.0) | 160 (9.6) | 162 (11.1) | 0.083 |
| Neurological diseases | 655 (9.1) | 199 (9.5) | 206 (10.3) | 125 (7.5) | 125 (8.6) | 0.023 |
| Diabetes mellitus | 526 (7.3) | 169 (8.0) | 141 (7.1) | 121 (7.3) | 95(6.5) | 0.358 |
| Liver diseases | 356 (4.9) | 87 (4.1) | 109 (5.5) | 91(5.5) | 69 (4.7) | 0.161 |
| Malignancy | 266 (3.7) | 73 (3.5) | 273 (13.7) | 55 (3.3) | 58 (4.0) | 0.600 |
| Sickle cell disease | 94 (1.3) | 29 (1.4) | 19 (1.0) | 32 (1.9) | 14 (1.0) | 0.040 |
| Severe asthma | 30 (0.4) | 15 (0.7) | 6 (0.3) | 3 (0.2) | 6 (0.4) | 0.061 |
| Thyroid | 22 (0.3) | 10 (0.5) | 9 (0.5) | 0 (0.0) | 3 (0.2) | 0.029 |
| Others /combined | 511 (7.1) | 142 (6.7) | 125 (6.3) | 130 (7.8) | 114 (7.8) | 0.178 |
Figure 1Frequency (proportions) of the pattern of admission of communicable and non-communicable diseases from 2017–2020 in Gadarif Hospital in Eastern Sudan.
Frequency (Proportions) of the Pattern of Mortality of the Communicable and Non-Communicable Disease During 2017–2020 in Gadarif Hospital Eastern Sudan
| Disease | Total (n=674) | 2017 (n=199) | 2018 (n=187) | 2019 (n=155) | 2020 (n=133) | P |
|---|---|---|---|---|---|---|
| Sepsis | 107 (15.9) | 30 (15.1) | 28 (15.0) | 27 (17.4) | 22 (16.5) | 0.912 |
| Tuberculosis | 51 (7.6) | 15 (7.5) | 19(10.2) | 11 (7.1) | 6 (4.5) | 0.305 |
| Severe pneumonia | 49 (7.3) | 15 (7.5) | 14 (7.5) | 11 (7.1) | 9 (6.8) | 0.993 |
| Visceral leishmaniasis | 40 (5.9) | 14 (7.0) | 8 (4.3) | 7 (4.5) | 11 (8.3) | 0.360 |
| Gastroenteritis | 28 (4.2) | 10 (5.0) | 9 (4.8) | 6 (3.9) | 3 (2.3) | 0.611 |
| Severe malaria | 20 (3.0) | 2 (1.0) | 5 (2.7) | 5 (5.2) | 5 (3.8) | 0.133 |
| Viral hepatitis | 17 (2.5) | 3 (1.5) | 2 (1.1) | 8 (5.2) | 4 (3.0) | 0.073 |
| Urinary tract infection | 15 (2.2) | 4 (2.0) | 7 (3.7) | 4 (2.6) | 0 (0.0) | 0.162 |
| HIV/AIDs | 13 (1.9) | 6 (3.0) | 3 (1.6) | 3 (1.9) | 1 (0.8) | 0.509 |
| Enteric fever | 1 (0.1) | 0 (0.0) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 0.456 |
| Others /combined | 15 (2.2) | 4 (2.0) | 7 (3.7) | 4 (2.6) | 0 (0.0) | 0.162 |
| Cardiovascular diseases | 150 (22.3) | 47 (23.6) | 36 (19.3) | 31 (20.0) | 36 (27.1) | 0.331 |
| Neurological diseases | 114 (16.9) | 32 (16.1) | 36 (19.3) | 19 (12.3) | 27 (20.3) | 0.231 |
| Renal diseases | 94 (13.9) | 32 (16.1) | 19 (10.2) | 23 (14.8) | 20 (15.0) | 0.358 |
| Snake bite | 56 (8.3) | 18 (9.0) | 21 (11.2) | 11 (7.1) | 6 (4.5) | 0.168 |
| Malignancy | 55 (8.2) | 20 (10.1) | 10 (5.3) | 13 (8.4) | 12 (9.0) | 0.382 |
| Diabetes mellitus | 53 (7.9) | 10 (5.0) | 15 (8.0) | 13 (8.4) | 15 (11.3) | 0.220 |
| Liver diseases | 49 (7.3) | 12 (6.0) | 7 (3.7) | 21 (13.5) | 9(6.8) | 0.005 |
| Asthma | 5 (0.7) | 5 (2.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.007 |
| Sickle cell disease | 3 (0.4) | 0 (0.0) | 1 (0.5) | 2 (1.3) | 0 (0.0) | 0.260 |
| Thyroid | 1 (0.1) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.495 |
| Others /combined | 49 (7.3) | 12 (6.0) | 7 (3.7) | 21 (13.5) | 9(6.8) | 0.005 |
Figure 2Frequency (proportions) of the pattern of mortality of communicable and non-communicable diseases from 2017–2020 in Gadarif Hospital in Eastern Sudan.
The Case Fatality Rate of the Communicable and Non-Communicable Disease During 2017–2020 in Gadarif Hospital Eastern Sudan
| Disease | Frequency of the Admitted Patients | Frequency of the Patients Died | Case Fatality Rate |
|---|---|---|---|
| Sepsis | 511 | 107 | 20.9 |
| Severe pneumonia | 321 | 49 | 15.3 |
| Tuberculosis | 416 | 51 | 12.3 |
| HIV/AIDs | 111 | 13 | 11.7 |
| Viral hepatitis | 166 | 17 | 10.2 |
| Urinary tract infection | 147 | 15 | 10.2 |
| Gastroenteritis | 436 | 28 | 6.4 |
| Enteric fever | 16 | 1 | 6.3 |
| Visceral leishmaniasis | 867 | 40 | 4.6 |
| Severe malaria | 488 | 20 | 4.1 |
| Others /combined | 27 | 2 | 7.4 |
| Malignancy | 266 | 55 | 20.7 |
| Neurological diseases | 655 | 114 | 17.4 |
| Severe asthma | 20 | 5 | 16.7 |
| Renal diseases | 683 | 94 | 13.8 |
| Liver diseases | 356 | 49 | 13.8 |
| Cardiovascular diseases | 1331 | 150 | 11.3 |
| Diabetes mellitus | 526 | 53 | 10.1 |
| Snake bite | 932 | 56 | 6.0 |
| Thyroid disease | 22 | 1 | 4.5 |
| Sickle cell disease | 94 | 3 | 3.2 |
| Others /combined | 24 | 2 | 8.3 |
Figure 3The case fatality rate of communicable and non-communicable diseases from 2017–2020 in Gadarif Hospital in Eastern Sudan.
Cox Regression (Adjusted and Non-Adjusted) Analysis for Factors Determining the In-Patient Mortality During 2017–2020 in Gadarif Hospital Eastern Sudan
| Characteristics | Deaths (Number = 674) | No Deaths (Number = 6556) | Univariate | Adjusted | |||||
|---|---|---|---|---|---|---|---|---|---|
| Frequency | Proportion | Frequency | Proportion | HR (95% CI) | P | HR (95% CI) | P | ||
| Age* | 60.0 | 33.0 | 45.0 | 33.0 | 1.16 (1.13‒1.20) | <0.001 | 1.02 (1.01‒1.03) | <0.001 | |
| Sex | Female | 235 | 34.9 | 1986 | 30.3 | 1.20 (1.02‒1.41) | 0.021 | 1.13 (0.96‒1.33) | 0.124 |
| Male | 439 | 65.1 | 4570 | 69.7 | Reference | Reference | |||
| Sepsis | No | 567 | 84.1 | 6152 | 93.8 | Reference | Reference | <0.001 | |
| Yes | 107 | 15.9 | 404 | 6.2 | 2.82 (2.29‒3.47) | <0.001 | 1.41(1.93‒3.01) | ||
| Tuberculosis | No | 623 | 92.4 | 6191 | 94.4 | Reference | Reference | 0.003 | |
| Yes | 51 | 7.6 | 365 | 5.6 | 1.24 (0.93‒1.65) | 0.137 | 1.56 (1.16‒2.10) | ||
| Severe pneumonia | No | 625 | 92.7 | 6284 | 95.9 | Reference | Reference | 0.002 | |
| Yes | 49 | 7.3 | 272 | 4.1 | 1.93 (1.44‒2.59) | <0.001 | 1.59 (1.18‒2.13) | ||
| Visceral leishmaniasis | Yes | 40 | 5.8 | 827 | 12.6 | 0.14 (0.10‒0.19) | <0.001 | 0.24 (17‒0.35) | 0.022 |
| No | 634 | 94.1 | 5729 | 87.4 | Reference | Reference | |||
| Cardiovascular diseases | No | 524 | 77.7 | 5375 | 82.0 | Reference | Reference | 0.170 | |
| Yes | 150 | 22.3 | 1181 | 18.0 | 1.46 (1.21‒1.75) | <0.001 | 1.14 (0.94‒1. 39) | ||
| Neurological diseases | No | 560 | 83.1 | 6015 | 91.7 | Reference | Reference | <0.001 | |
| Yes | 114 | 16.9 | 541 | 8.3 | 2.26 (1.84‒2.76) | <0.001 | 1.81 (1.46‒2.25) | ||
| Renal diseases | No | 580 | 86.1 | 5967 | 91.0 | Reference | Reference | 0.012 | |
| Yes | 94 | 13.9 | 589 | 9.0 | 1.48 (1.18‒1.84) | <0.001 | 1.33 (1.06‒1.66) | ||
| Years | 2017 | 199 | 9.5 | 1905 | 90.5 | Reference | Reference | ||
| 2018 | 187 | 9.4 | 1812 | 90.6 | 1.01(0.82‒1.23) | 0.921 | |||
| 2019 | 155 | 9.3 | 1511 | 90.7 | 1.01 (0.82‒1.25) | 0.904 | |||
| 2020 | 133 | 9.1 | 1328 | 90.9 | 0.95 (0.76‒1.19) | 0.957 | |||
Note: *Median (interquartile).